- Hair thinning during GLP-1 treatment is typically caused by rapid weight loss, not the medication itself
- Adequate protein intake is the most important prevention strategy
- Hair loss is usually temporary and resolves as weight stabilizes
- PEAK’s dietitian ensures your nutrition supports healthy hair during treatment
If you have noticed more hair in your brush or shower drain since starting a GLP-1 medication like Wegovy, Ozempic, or Zepbound, you are not imagining things. Hair thinning is a recognized concern among patients undergoing medical weight loss — and it is more common than most people expect.
The good news: it is almost always temporary, and there are concrete steps you can take to minimize it. This guide covers why it happens, who is most at risk, and what you can do about it.
Is hair loss a real side effect?
Yes. Hair thinning has been reported in clinical trials for GLP-1 receptor agonists, including both semaglutide and tirzepatide. In the STEP trials for Wegovy, hair-related adverse events were reported at higher rates in the treatment group compared to placebo. In the SURMOUNT trials for Zepbound (tirzepatide), alopecia was listed among the most common adverse events, affecting approximately 5% of participants at higher doses.
Despite this, hair loss is often underemphasized in patient counseling. Many patients are surprised when it happens — and some worry it means something is wrong with the medication or their health. In the vast majority of cases, it is a predictable response to rapid body changes, not a sign of a deeper problem.
Hair thinning was reported more frequently in patients who lost weight faster and in greater amounts. This pattern strongly suggests the hair loss is related to the weight loss itself rather than a direct pharmacological effect of the medication.
Why it happens
The medical term for this type of hair loss is telogen effluvium. It is not unique to GLP-1 medications — it occurs after any significant physiological stress on the body, including rapid weight loss, surgery, pregnancy, severe illness, or major dietary changes.
Here is how it works:
- Hair growth occurs in cycles. At any given time, about 85–90% of your hair is in the active growth phase (anagen) and 10–15% is in the resting phase (telogen). After the resting phase, those hairs fall out naturally to make room for new growth.
- Rapid weight loss triggers a shift. When your body undergoes a significant caloric deficit or rapid weight change, it redirects energy and nutrients toward essential functions. Hair growth is not essential. More follicles are pushed into the resting phase simultaneously.
- The shedding appears 2–4 months later. Because the telogen (resting) phase lasts about 3 months, you typically notice increased shedding several weeks to months after the triggering event — which is why many patients connect it to the medication rather than the weight loss itself.
The medication is not attacking your hair follicles. Your body is temporarily reprioritizing its resources during a period of rapid change.
Nutritional deficiencies can compound the problem. When you are eating significantly less food, you may not be getting enough protein, iron, zinc, biotin, or vitamin D — all of which are essential for healthy hair growth. This is why nutrition is the most actionable lever you have.
Who is most at risk
Not every patient on a GLP-1 medication will experience hair thinning. Several factors increase your risk:
- Rapid weight loss. Patients who lose weight quickly — particularly more than 1–2 pounds per week consistently — are at higher risk. The faster the weight comes off, the more stress it places on the body.
- Inadequate protein intake. Protein is the building block of hair. When caloric intake drops significantly, protein is often the first macronutrient that falls short. This is the single most modifiable risk factor.
- Pre-existing nutritional deficiencies. If you were already low in iron, zinc, vitamin D, or B vitamins before starting treatment, the additional caloric restriction can push those levels into ranges that affect hair health.
- Chronic stress. Emotional and physical stress independently contribute to telogen effluvium. Combining the stress of a major lifestyle change with the physiological stress of weight loss can amplify the effect.
- Age. Hair naturally thins with age. Patients over 50 may be more susceptible to noticeable thinning during weight loss, as they have less hair density in reserve.
Prevention strategies
You may not be able to eliminate the risk of hair thinning entirely during weight loss, but you can significantly reduce it. These strategies are listed in order of impact:
Prioritize protein intake
This is the single most important thing you can do. Protein provides the amino acids your body needs to build keratin — the structural protein that makes up your hair. When protein intake drops, hair growth is one of the first things your body deprioritizes.
Aim for a minimum of 60–80 grams of protein per day, and more if you are physically active. Your PEAK dietitian can help you identify the right target based on your body weight and activity level.
Animal sources: Chicken breast, turkey, fish, eggs, Greek yogurt, cottage cheese.
Plant sources: Lentils, chickpeas, tofu, tempeh, edamame, quinoa.
Supplements: Whey or plant-based protein powder can help bridge the gap when appetite is low.
Monitor iron and zinc levels
Both iron and zinc are essential for hair follicle function. Iron deficiency is one of the most common nutritional causes of hair loss in women, and it can be worsened by reduced food intake during GLP-1 treatment. Ask your PEAK clinician to check your ferritin (stored iron) and zinc levels, especially if you are experiencing noticeable thinning.
Consider biotin supplementation
Biotin (vitamin B7) supports keratin production and is commonly recommended for hair health. While research on biotin supplementation is mixed for people who are not deficient, many patients find it helpful as part of an overall nutrition strategy. A dose of 2,500–5,000 mcg daily is commonly used. Discuss this with your PEAK clinician before starting.
Aim for gradual weight loss
The dose titration schedule for GLP-1 medications is designed to produce gradual, sustainable weight loss. If you are losing weight very rapidly, your clinician may adjust your approach — not by stopping the medication, but by ensuring you are eating enough to support your body through the transition.
Avoid extreme calorie restriction
GLP-1 medications reduce appetite, which is part of how they work. But reduced appetite should not become starvation. Eating too little — especially below 1,200 calories per day — dramatically increases the risk of nutritional deficiencies that affect hair, bone, and muscle health. Your PEAK care team will help you find the right caloric floor.
The role of nutrition
Nutrition is the most actionable factor in preventing and reversing hair thinning during GLP-1 treatment. Your hair follicles need specific nutrients to function, and when your overall intake drops, targeted nutrition becomes even more important.
Protein: the foundation
Hair is approximately 95% keratin, a protein. Without adequate amino acid supply, your body simply cannot produce new hair at a normal rate. We recommend a minimum of 60–80 grams of protein daily for patients on GLP-1 medications. For patients who are more active or have higher body mass, the target may be higher.
This is not about eating more food overall — it is about making sure that the food you do eat is protein-rich. When appetite is suppressed, every bite counts. Prioritize protein at every meal and snack.
Iron-rich foods
Iron carries oxygen to your hair follicles. Low iron is one of the most common correctable causes of hair loss in women, and it can be worsened by reduced food intake during GLP-1 treatment. Good sources include lean red meat (in moderation), spinach, lentils, fortified cereals, and shellfish. Pairing iron-rich foods with vitamin C improves absorption.
Omega-3 fatty acids
Omega-3s support scalp health and may promote hair density. Fatty fish like salmon, mackerel, and sardines are excellent sources. If fish intake is limited, a fish oil or algae-based supplement can help. Walnuts, chia seeds, and flaxseeds also provide plant-based omega-3s.
Vitamin D
Vitamin D plays a role in the hair growth cycle, and deficiency has been associated with telogen effluvium. Many adults — particularly those in the mid-Atlantic region — are already low in vitamin D. Your PEAK clinician can check your levels and recommend supplementation if needed.
Every PEAK patient on a GLP-1 medication receives individualized nutrition guidance from our dietitian. We do not just prescribe the medication and hope for the best — we actively monitor your nutrient intake and adjust your plan to protect your hair, bones, and muscle mass throughout treatment.
When does it stop?
This is the question every patient wants answered, and the answer is encouraging: telogen effluvium is almost always temporary.
For most patients, the timeline looks like this:
- Months 1–3 of treatment: Rapid weight loss begins. Hair follicles start shifting into the resting phase, but you may not notice anything yet.
- Months 3–6: Increased shedding becomes noticeable. This is when patients typically report finding more hair in their brush, on their pillow, or in the shower drain.
- Months 6–9: As weight stabilizes and nutrition is optimized, new hair begins growing in. Shedding gradually decreases.
- Months 9–12: Most patients report that their hair has returned to its normal density, or close to it. Some notice that the new growth is even healthier than before, thanks to improved nutrition.
The shedding is temporary. The hair comes back. And with the right nutrition strategy, it often comes back stronger than before.
The key factors that accelerate recovery are stabilizing your weight (even at a lower level), maintaining consistent protein intake, and correcting any nutritional deficiencies. Patients who address nutrition proactively tend to experience less shedding and faster regrowth.
When to see a provider
While most hair thinning during GLP-1 treatment is telogen effluvium and resolves on its own, certain signs warrant a clinical evaluation:
- Excessive shedding that goes beyond normal thinning — if you are losing large clumps of hair or notice significant bald spots, this may not be simple telogen effluvium.
- Patchy hair loss. Telogen effluvium causes diffuse, even thinning. If you notice distinct patches of hair loss, this could indicate alopecia areata or another condition that requires different treatment.
- Hair loss that has not improved after 6 months of stable weight and adequate nutrition. At this point, other causes should be investigated.
- Accompanying symptoms such as fatigue, brittle nails, dry skin, or cold intolerance — these could suggest thyroid dysfunction or other underlying conditions that cause hair loss independently.
At PEAK, we do not assume all hair thinning is “just from the weight loss.” We run bloodwork to check thyroid function, iron, ferritin, zinc, vitamin D, and other markers that affect hair health. If something else is going on, we catch it early.
Hair thinning during GLP-1 treatment is a manageable side effect, not a reason to stop treatment. With the right nutritional strategy and clinical monitoring, most patients move through it without lasting impact. The weight loss benefits, metabolic improvements, and long-term health gains far outweigh a temporary period of increased shedding.
At PEAK, good care means watching every detail — including this one. We monitor your nutrition, your labs, and your overall well-being so that your treatment produces the best possible outcome across every dimension of your health.
Boxed warning — thyroid C-cell tumors: GLP-1-based medications (including semaglutide and tirzepatide) carry an FDA boxed warning for thyroid C-cell tumors observed in rodent studies. These medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). Tell your provider immediately if you notice a lump in your neck, difficulty swallowing, or persistent hoarseness.
Medication labeling reminder: Ozempic (semaglutide) and Mounjaro (tirzepatide) are FDA-approved for type 2 diabetes only. For weight management, the FDA-approved options are Wegovy (semaglutide) and Zepbound (tirzepatide).
